Observed Signal · Sep 9, 2026 · Funding · Source: Tech.eu (European Tech & Deals) · Impact: 1/5 · Sentiment: Positive
Healthcare AI Market: Anemo Labs Raises £700K for AI E-Nose
London-based deeptech startup Anemo Labs has raised £700,000 in pre-seed funding to develop an electronic nose (e-nose) that combines sensor hardware with AI to detect volatile organic compounds (VOCs). The round was led by Zinc and SFC Capital with support from Innovate UK. Founded in 2025 by Koye Sodipo, the company initially targets healthcare applications, analyzing VOCs from urine for non-invasive disease screening. Anemo's in-house sampling platform can collect and label up to 5,000 smells daily, and early tests using the Sniffin' Sticks protocol achieved 84.15% accuracy across 12 scent categories. The funding will advance sensor chemistry, expand data collection, and support clinical validation.
Early-stage funding in a niche deeptech sector (e-nose for healthcare) with limited direct immediate impact on the AdTech/MarTech industry.
Wichtigste Kernpunkte & Evidenz
- Anemo Labs raised £700,000 in pre-seed funding.
- The funding round was led by Zinc and SFC Capital, with support from Innovate UK.
- Anemo Labs is developing an electronic nose combining sensor hardware and AI to detect VOCs.
- The company's technology aims for non-invasive disease screening via urine analysis.
- Early tests showed 84.15% accuracy in classifying 12 scent categories using Sniffin' Sticks protocol.
Verknüpfte Unternehmen
1 verknüpfte UnternehmenOntology Mapping & Concepts
Track Real-Time Market Signals & Shifts
Set up custom watchlists to receive automated, evidence-grounded executive digests whenever material signals or shifts occur across your tracked landscape.